{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:59:55Z","timestamp":1648558795269},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s15006-013-0665-y","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T04:48:14Z","timestamp":1369198094000},"page":"56-62","source":"Crossref","is-referenced-by-count":1,"title":["Das geht Ihren Patienten an die Nieren"],"prefix":"10.1007","volume":"155","author":[{"given":"Christoph","family":"Schmaderer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Moog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,23]]},"reference":[{"key":"665_CR1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","volume":"363","author":"B.A. Cooper","year":"2010","unstructured":"Cooper BA, Branley P, Bulfone L et al. A randomized, controlled trial of early versus late initiation of dialysis. The New England journal of medicine 2010;363:609\u2013619","journal-title":"The New England journal of medicine"},{"key":"665_CR2","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","volume":"367","author":"G.M. Chertow","year":"2012","unstructured":"Chertow GM, Block GA, Correa-Rotter R et al. Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis. The New England journal of medicine 2012;367:2482\u20132494","journal-title":"The New England journal of medicine"},{"key":"665_CR3","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/ki.2012.280","volume":"82","author":"J. Radhakrishnan","year":"2012","unstructured":"Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient. Kidney international 2012;82:840\u2013856","journal-title":"Kidney international"},{"key":"665_CR4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"L.H. Beck Jr.","year":"2009","unstructured":"Beck LH, Jr., Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. The New England journal of medicine 2009;361:11\u201321","journal-title":"The New England journal of medicine"},{"key":"665_CR5","doi-asserted-by":"crossref","unstructured":"Kanigicherla D, Gummadova J, McKenzie EA et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney international 2013","DOI":"10.1038\/ki.2012.486"},{"key":"665_CR6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","volume":"363","author":"G. Walz","year":"2010","unstructured":"Walz G, Budde K, Mannaa M et al. Everolimus in patients with autosomal dominant polycystic kidney disease. The New England journal of medicine 2010;363:830\u2013840","journal-title":"The New England journal of medicine"},{"key":"665_CR7","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"V.E. Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. The New England journal of medicine 2012;367:2407\u20132418.","journal-title":"The New England journal of medicine"},{"key":"665_CR8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"W.C. Cushman","year":"2010","unstructured":"Cushman WC, Evans GW, Byington RP et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. The New England journal of medicine 2010;362:1575\u20131585","journal-title":"The New England journal of medicine"},{"key":"665_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-6143.2011.03785.x","volume":"12","author":"F. Vincenti","year":"2012","unstructured":"Vincenti F, Larsen CP, Alberu J et al. Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2012;12:210\u2013217","journal-title":"American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons"},{"key":"665_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"J.C. Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis and rheumatism 2013;65:1\u201311","journal-title":"Arthritis and rheumatism"},{"key":"665_CR11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"R.B. Jones","year":"2010","unstructured":"Jones RB, Tervaert JW, Hauser T et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. The New England journal of medicine 2010;363:211\u2013220","journal-title":"The New England journal of medicine"},{"key":"665_CR12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"J.H. Stone","year":"2010","unstructured":"Stone JH, Merkel PA, Spiera R et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. The New England journal of medicine 2010;363:221\u2013232","journal-title":"The New England journal of medicine"},{"key":"665_CR13","doi-asserted-by":"crossref","first-page":"366","DOI":"10.7326\/0003-4819-119-5-199309010-00003","volume":"119","author":"D.T. Boumpas","year":"1993","unstructured":"Boumpas DT, Austin HA, 3rd, Vaughan EM et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Annals of internal medicine 1993;119:366\u2013369","journal-title":"Annals of internal medicine"},{"key":"665_CR14","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"G.K. Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Annals of the rheumatic diseases 2012;71:1771\u20131782","journal-title":"Annals of the rheumatic diseases"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-013-0665-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-013-0665-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-013-0665-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T10:13:03Z","timestamp":1600855983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-013-0665-y"}},"subtitle":["Update Nephrologie 2013"],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s15006-013-0665-y","relation":{},"ISSN":["1438-3276"],"issn-type":[{"value":"1438-3276","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}